Needham G K, Sherbet G V, Farndon J R, Harris A L
Br J Cancer. 1987 Jan;55(1):13-6. doi: 10.1038/bjc.1987.3.
The high molecular weight form of the plasminogen activator urokinase (54 kD) binds to specific receptor sites on the cell membrane of breast carcinomas by its inactive "A" chain. The binding is of high affinity (range of dissociation constants: 5.6 X 10(-11) to 4 X 10(-10) mol l-1 and there were between 20 to 250 fmol of binding sites per milligram of membrane protein) and equilibrium is reached in 60 min. No competition for binding sites was observed with epidermal growth factor, tissue plasminogen activator or the low molecular weight form of urokinase (33 kD). Cross-linking experiments suggest that the receptor is a monomeric unit of molecular weight of 50 kD. This binding site provides a mechanism for the incorporation of urokinase into the cell membrane.
纤溶酶原激活剂尿激酶的高分子量形式(54 kD)通过其无活性的“A”链与乳腺癌细胞膜上的特定受体位点结合。这种结合具有高亲和力(解离常数范围:5.6×10⁻¹¹至4×10⁻¹⁰ mol l⁻¹,每毫克膜蛋白有20至250 fmol的结合位点),60分钟内达到平衡。未观察到表皮生长因子、组织纤溶酶原激活剂或低分子量形式的尿激酶(33 kD)对结合位点的竞争。交联实验表明,该受体是分子量为50 kD的单体单元。这种结合位点为尿激酶掺入细胞膜提供了一种机制。